Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa

Joseph N Jarvis, Thomas S Harrison, Stephen D Lawn, Graeme Meintjes, Robin Wood and Susan Cleary

PLOS ONE, 2013, vol. 8, issue 7, 1-9

Abstract: Objectives: Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive. Prior to programmatic implementation in South Africa we performed a cost-effectiveness analysis of alternative preventive strategies for CM. Design: Cost-effectiveness analysis. Methods: Using South African data we modelled the cost-effectiveness of four strategies for patients with CD4 cell-counts

Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0069288 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 69288&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0069288

DOI: 10.1371/journal.pone.0069288

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().